| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 00:01 | XFRA NEW INSTRUMENTS AVAILABLE ON 13.08.2026 | 114 | Xetra Newsboard | The following instruments on XETRA do have their first trading 13.08.2026 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 13.08.2026
Aktien
1 CA40173G1019 GuideAI Health Corp.
2... ► Artikel lesen | |
| 10.07. | GuideAI Health Corp: GuideAI Health hires Upswitch, BTV-Business for ads | 9 | Stockwatch | ||
| 10.07. | GuideAI Health Corp.: GuideAI Health Announces Marketing and Communications Programs | 19 | GlobeNewswire (USA) | ||
| 06.07. | GuideAI Health Corp: GuideAI Health appoints Benenati to advisory board | 1 | Stockwatch | ||
| GUIDEAI HEALTH Aktie jetzt für 0€ handeln | |||||
| 06.07. | GuideAI Health Corp.: GuideAI Health Appoints Renowned Interventional Radiologist Dr. James Benenati to Advisory Board Following FDA 510(k) Clearance of VAOT | 87 | GlobeNewswire (Europe) | BOSTON, July 06, 2026 (GLOBE NEWSWIRE) -- GuideAI Health Corp. (Cboe CA: GDAI) ("GuideAI" or the "Company") recently received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for... ► Artikel lesen | |
| 03.07. | GuideAI Health Corp: GuideAI hires DS Market for market-making services | 1 | Stockwatch | ||
| 02.07. | GuideAI Health Corp. Engages Market Maker | 2 | GlobeNewswire (USA) | ||
| 30.06. | GuideAI Health Corp: GuideAI Health to trade on Cboe Canada on June 29 | 1 | Stockwatch | ||
| 29.06. | GuideAI Health Corp. to Begin Trading on Cboe Canada Under the Symbol "GDAI" | 159 | GlobeNewswire (Europe) | BOSTON, June 29, 2026 (GLOBE NEWSWIRE) -- GuideAI Health Corp. ("GuideAI" or the "Company") (Cboe CA: GDAI) is pleased to report that the Company has received final approval to list its common shares... ► Artikel lesen | |
| 25.06. | GuideAI Health Corp: GuideAI Health to trade on Cboe Canada June 29 | 1 | Stockwatch |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| ALIGNMENT HEALTHCARE | 13,520 | 0,00 % | Can ALHC's Raised 2026 Outlook Offset Heavier Second-Half Spending? | ||
| LIFESTANCE HEALTH GROUP | 12,230 | 0,00 % | LifeStance Health Group, Inc.: LifeStance Reports Strong Second Quarter 2026 Financial Results and Raises Full Year Outlook | SCOTTSDALE, Ariz., Aug. 06, 2026 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation's largest providers of outpatient mental healthcare, today announced financial... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 59,69 | +0,02 % | BrightSpring Health Services, Inc. Reports Second Quarter 2026 Financial Results and Increases Full Year 2026 Guidance | LOUISVILLE, Ky., July 31, 2026 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ: BTSG), a leading provider of home and community-based health services... ► Artikel lesen | |
| HEARTFLOW | 29,850 | 0,00 % | Heartflow, Inc.: Heartflow Reports First Quarter 2026 Financial Results and Raises Full Year 2026 Guidance | SAN FRANCISCO, May 14, 2026 (GLOBE NEWSWIRE) -- Heartflow, Inc. (Heartflow) (Nasdaq: HTFL), the leader in AI technology for coronary artery disease (CAD), today reported financial results for the... ► Artikel lesen | |
| BILLIONTOONE | 97,45 | 0,00 % | Diagnostiksektor: BTIG kürt BillionToOne zum Top-Pick | ||
| VALION BIO | 0,225 | -0,58 % | Valion Bio, Inc.: Valion Bio Announces U.S. Government-Funded Entolimod Studies Targeting Lethal Radiation-Induced GI Injury | AFRRI/NIAID Program to Advance Safety and Therapeutic Studies in Rapid Sequence; Top-Line Therapeutic Data Expected in Early FallStudy drug delivered • IACUC approval secured • Safety study planned... ► Artikel lesen | |
| PROGYNY | 25,400 | 0,00 % | Progyny, Inc. Announces Second Quarter 2026 Results | Reports Record Quarterly Revenue, Gross Profit and Adjusted EBITDARobust Selling Season Activity Continues to Reflect Strong Demand for Women's Health, Family Building SolutionsValue Returned to Shareholders... ► Artikel lesen | |
| AVEANNA HEALTHCARE | 9,040 | 0,00 % | Aveanna Healthcare Holdings Q2 2026 Earnings Preview | ||
| GENEDX | 82,32 | 0,00 % | GeneDx launches online exome testing for pediatric patients | ||
| PROCEPT BIOROBOTICS | 21,260 | 0,00 % | PROCEPT BioRobotics Reports First Quarter 2026 Financial Results | SAN JOSE, Calif., April 29, 2026 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
| PRIVIA HEALTH GROUP | 21,560 | +0,09 % | Privia Health Group, Inc.: Privia Health Reports Strong Second Quarter and Year-to-Date 2026 Results | 2Q'26 Net Income of $9.0M, +236.7% from 2Q'252Q'26 Adjusted EBITDA of $37.4M, +29.1% from 2Q'25Full-Year 2026 Guidance Raised for All Key Financial Metrics ARLINGTON, Va., Aug. 06, 2026 (GLOBE NEWSWIRE)... ► Artikel lesen | |
| ADAPTHEALTH | 5,780 | +0,17 % | Morning Market Movers: Ameresco, Inno Holdings, AdaptHealth, Ibotta See Big Swings | OTTAWA (dpa-AFX) - At 7:50 a.m. ET on Tuesday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the opening... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 41,280 | +0,66 % | BARCLAYS stuft FMC FRESENIUS MEDICAL CARE AG auf 'Equal Weight' | LONDON (dpa-AFX Analyser) - Die britische Investmentbank Barclays hat das Kursziel für FMC von 46,00 auf 44,50 Euro gesenkt, aber die Einstufung auf "Equal Weight" belassen. Zu den Behandlungszahlen... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 39,200 | +0,44 % | DZ BANK stuft Siemens Healthineers auf 'Kaufen' | FRANKFURT (dpa-AFX Analyser) - Die DZ Bank hat Siemens Healthineers bei einem fairen Aktienwert von 53 Euro auf "Kaufen" belassen. Im Fokus der Telefonkonferenz habe das Geschäftsjahr 2027 gelegen,... ► Artikel lesen | |
| SANARA MEDTECH | 34,290 | 0,00 % | Sanara MedTech Inc. Reports Second Quarter 2026 Financial Results (Unaudited) | FORT WORTH, TX, Aug. 11, 2026 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. ("Sanara," "Sanara MedTech," the "Company," "we," "our" or "us") (Nasdaq: SMTI), a medical technology company focused on developing... ► Artikel lesen |